Vés al contingut

A Phase 2, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Assess the Safety, Efficacy, and Tolerability of ARGX-117 in Improving Allograft Function in Recipients of a Deceased Donor Renal Allograft at Risk for Delayed Graft Function

Obert
  • Codi protocol: ARGX-117-2201
  • Codi EudraCT: 2022-503091-89-00
  • Grup de recerca: Nefrologia i Trasplantament Renal
  • Servei: Nefrologia
  • Investigador/a principal:  Moreso Mateos, Francesc
  • Fase: Fase II
  • Estat: Reclutant voluntaris